RCMT Revenue Jumps 16% YOY, But Net Income Dips Amid Rising Costs

TL;DR

**RCMT's top-line growth is impressive, but rising expenses are eating into profits, making it a 'show-me' story on cost control.**

AI Summary

RCM Technologies, Inc. reported a significant increase in revenue for both the thirteen and thirty-nine weeks ended September 27, 2025. Revenue for the thirteen weeks rose to $70.289 million from $60.365 million in the prior year, a 16.4% increase. For the thirty-nine weeks, revenue climbed to $232.928 million from $201.468 million, an increase of 15.6%. Despite this revenue growth, net income for the thirteen weeks decreased to $2.259 million from $2.746 million, a 17.7% decline, and for the thirty-nine weeks, it slightly fell to $10.230 million from $10.460 million, a 2.2% decrease. This dip in net income occurred despite a higher gross profit, which reached $19.410 million for the quarter and $63.665 million for the thirty-nine weeks, primarily due to increased selling, general, and administrative expenses, which rose to $14.933 million for the quarter and $45.179 million for the thirty-nine weeks. The company also saw a substantial increase in interest expense and other, net, rising to $1.885 million for the thirty-nine weeks from $1.551 million. Cash and cash equivalents significantly decreased from $4.729 million at December 28, 2024, to $1.309 million at September 27, 2025, largely due to net cash used in financing activities, including $5.115 million for treasury stock purchases.

Why It Matters

RCMT's strong revenue growth, particularly in Specialty Health Care and Engineering, signals robust demand for its services, which is positive for investors and employees. However, the decline in net income despite higher gross profit, driven by increased SG&A and interest expenses, raises concerns about profitability and operational efficiency. This could impact investor confidence and RCMT's ability to compete effectively against rivals like TEKsystems or Aerotek if cost controls aren't managed. Customers might see continued service quality, but the company's reduced cash position could limit future investments in innovation or expansion, potentially affecting its long-term market position.

Risk Assessment

Risk Level: medium — The company's cash and cash equivalents decreased significantly from $4.729 million to $1.309 million, a 72.3% drop, indicating reduced liquidity. Additionally, net income declined by 17.7% for the thirteen weeks and 2.2% for the thirty-nine weeks despite strong revenue growth, suggesting potential challenges in managing operating costs and maintaining profitability.

Analyst Insight

Investors should monitor RCMT's upcoming earnings reports closely for signs of improved cost management and a rebound in net income. Consider holding existing positions but deferring new investments until there's clear evidence of enhanced profitability and cash flow stability, especially given the significant treasury stock purchases impacting cash.

Financial Highlights

revenue

$232.928M

net Income

$10.230M

cash Position

$1.309M

revenue Growth

+15.6%

Key Numbers

• $70.289M — Revenue (13 weeks) (Increased 16.4% from $60.365M year-over-year)
• $232.928M — Revenue (39 weeks) (Increased 15.6% from $201.468M year-over-year)
• $2.259M — Net Income (13 weeks) (Decreased 17.7% from $2.746M year-over-year)
• $10.230M — Net Income (39 weeks) (Decreased 2.2% from $10.460M year-over-year)
• $1.309M — Cash and Cash Equivalents (Decreased 72.3% from $4.729M at December 28, 2024)
• $14.933M — SG&A (13 weeks) (Increased from $13.018M year-over-year, impacting net income)
• $45.179M — SG&A (39 weeks) (Increased from $40.762M year-over-year, impacting net income)
• $5.115M — Treasury Stock Purchases (Significant cash outflow in financing activities for 39 weeks)
• $1.885M — Interest Expense (39 weeks) (Increased from $1.551M year-over-year)
• 7,410,510 — Shares Outstanding (As of November 5, 2025)

Key Players & Entities

• RCM TECHNOLOGIES, INC. (company) — Registrant
• NASDAQ Stock Market LLC (regulator) — Exchange where common stock is registered
• $70.289 million (dollar_amount) — Revenue for the thirteen weeks ended September 27, 2025
• $60.365 million (dollar_amount) — Revenue for the thirteen weeks ended September 28, 2024
• $232.928 million (dollar_amount) — Revenue for the thirty-nine weeks ended September 27, 2025
• $201.468 million (dollar_amount) — Revenue for the thirty-nine weeks ended September 28, 2024
• $2.259 million (dollar_amount) — Net income for the thirteen weeks ended September 27, 2025
• $2.746 million (dollar_amount) — Net income for the thirteen weeks ended September 28, 2024
• $1.309 million (dollar_amount) — Cash and cash equivalents at September 27, 2025
• $4.729 million (dollar_amount) — Cash and cash equivalents at December 28, 2024

FAQ

Risk Factors

• Liquidity and Cash Position [high — financial]: Cash and cash equivalents decreased significantly by 72.3% from $4.729 million at December 28, 2024, to $1.309 million at September 27, 2025. This reduction was primarily driven by net cash used in financing activities, notably $5.115 million for treasury stock purchases, raising concerns about short-term liquidity.
• Rising Operating Expenses [medium — financial]: Selling, General, and Administrative (SG&A) expenses increased to $14.933 million for the thirteen weeks and $45.179 million for the thirty-nine weeks ended September 27, 2025. This rise in operating costs outpaced revenue growth in percentage terms for the quarter, contributing to a decline in net income.
• Increased Interest Expense [medium — financial]: Interest expense and other, net, rose to $1.885 million for the thirty-nine weeks ended September 27, 2025, up from $1.551 million in the prior year. This increase adds to the company's cost structure and can negatively impact profitability, especially in a rising interest rate environment.
• Dependence on Key Personnel and Contracts [medium — operational]: While not explicitly detailed in the provided summary, companies like RCMT often rely on specialized talent and long-term client relationships. Disruptions in key personnel or contract losses could significantly impact revenue and operations.
• Competition in Technology and Staffing Services [medium — market]: The technology and staffing services industry is highly competitive. RCMT faces competition from numerous players, which can pressure pricing, margins, and market share. Sustaining growth requires continuous innovation and service differentiation.

Industry Context

RCM Technologies operates in the competitive technology and staffing services sector. This industry is characterized by a demand for specialized skills and a need for agile service providers. Trends include the increasing adoption of digital transformation services and the ongoing need for skilled IT professionals, creating both opportunities and challenges for companies like RCMT.

Regulatory Implications

As a publicly traded company, RCMT is subject to SEC regulations and reporting requirements. Compliance with accounting standards (GAAP) and timely filing of financial reports are critical. Any misstatements or failures in internal controls could lead to regulatory scrutiny and penalties.

What Investors Should Do

1. Monitor SG&A Expense Control
2. Analyze Cash Flow Trends
3. Evaluate Profitability Drivers

Key Dates

• 2025-09-27: End of Third Quarter 2025 — Reporting period for the 10-Q, showing significant revenue growth but a decline in net income and cash position.
• 2024-12-28: End of Fiscal Year 2024 — Reference point for the beginning cash balance of $4.729 million, highlighting the substantial decrease by Q3 2025.

Glossary

SG&A

Selling, General, and Administrative expenses. These are the costs associated with running a business that are not directly tied to the production of goods or services. (Increased SG&A expenses for RCMT in the reported periods directly impacted net income, despite revenue growth.)

Treasury Stock Purchases

The repurchase of a company's own shares from the open market. This reduces the number of outstanding shares and can be used to return capital to shareholders or offset dilution from stock options. (A significant use of cash ($5.115 million) for RCMT, contributing to the sharp decline in its cash and cash equivalents.)

Net Income

The profit remaining after all expenses, including taxes and interest, have been deducted from revenue. (Despite strong revenue growth, RCMT's net income decreased, indicating pressure on profitability from rising costs.)

Cash and Cash Equivalents

Highly liquid short-term investments that can be readily converted into cash, including currency on hand, bank deposits, and short-term government securities. (A substantial decrease in RCMT's cash position raises concerns about its short-term financial flexibility.)

Year-Over-Year Comparison

Compared to the prior year, RCM Technologies has demonstrated robust revenue growth, with a 16.4% increase for the thirteen weeks and 15.6% for the thirty-nine weeks ended September 27, 2025. However, this top-line expansion has not translated into improved profitability, as net income saw a decline of 17.7% for the quarter and 2.2% year-to-date. This divergence is primarily attributed to a substantial rise in Selling, General, and Administrative (SG&A) expenses and increased interest costs, alongside a significant reduction in the company's cash reserves.

Key Financial Figures

• $0.05 — ich registered Common Stock, par value $0.05 per share RCMT The NASDAQ Stock Mar

Filing Documents

• rcmt20250927_10q.htm (10-Q) — 1728KB
• ex_879405.htm (EX-31.1) — 8KB
• ex_879406.htm (EX-31.2) — 8KB
• ex_879407.htm (EX-32.1) — 4KB
• ex_879408.htm (EX-32.2) — 4KB
• 0001437749-25-033607.txt ( ) — 7420KB
• rcmt-20250927.xsd (EX-101.SCH) — 54KB
• rcmt-20250927_cal.xml (EX-101.CAL) — 50KB
• rcmt-20250927_def.xml (EX-101.DEF) — 362KB
• rcmt-20250927_lab.xml (EX-101.LAB) — 332KB
• rcmt-20250927_pre.xml (EX-101.PRE) — 399KB
• rcmt20250927_10q_htm.xml (XML) — 1347KB

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION Page Item 1. Condensed Consolidated Financial Statements Condensed Consolidated Balance Sheets as of September 27, 2025 (Unaudited) and December 28, 2024 4 Unaudited Condensed Consolidated Statements of Operations for the Thirteen and Thirty-Nine Weeks Ended September 27, 2025 and September 28, 2024 5 Unaudited Condensed Consolidated Statements of Comprehensive Income for the Thirty-Nine Weeks Ended September 27, 2025 and September 28, 2024 6 Unaudited Condensed Consolidated Statements of Changes in Stockholders' Equity for the Thirty-Nine Weeks Ended September 27, 2025 and September 28, 2024 7 Unaudited Condensed Consolidated Statements of Cash Flows for the Thirty-Nine Weeks Ended September 27, 2025 and September 28, 2024 9 Notes to Unaudited Condensed Consolidated Financial Statements 10 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 30 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 48 Item 4.

Controls and Procedures

Controls and Procedures 48

- OTHER INFORMATION

PART II - OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 49 Item 1A.

Risk Factors

Risk Factors 49 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 49 Item 3. Defaults Upon Senior Securities 49 Item 4. Mine Safety Disclosures 49 Item 5. Other Information 49 Item 6. Exhibits 50

Signatures

Signatures 51 2 CAUTIONARY NOTE REGARDING FORWARD LOOKING STATEMENTS This report and documents incorporated by reference into it may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are not historical facts but rather are based on current expectations, estimates and projections about our business and industry, and our beliefs and assumptions. Words such as "believes," "anticipates," "plans," "expects," "will," "goal," and similar expressions are intended to identify forward-looking statement. The inclusion of forward-looking statements should not be regarded as a representation by us that any of our plans will be achieved. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Such forward-looking information is also subject to various risks and uncertainties. Such risks and uncertainties include, but are not limited to, risks arising from our having a significant portion of our condensed consolidated revenues contributed by a concentrated group of customers; credit and collection risks; our claim experience related to workers' compensation and general liability insurance; the effects of changes in, or interpretations of laws and regulations governing, the healthcare industry, our workforce and the services that we provide, including state and local regulations pertaining to the taxability of our services and other labor-related matters such a minimum wage increases; the Company's expectations with respect to selling, general, and administrative expense; and the risk factors described in Part I, Item 1A, "Risk Factors" of our Annual Report on Form 10-K for the fiscal year ended December 28, 2024 and Part II, Item 1A "Risk Factors" of subsequent Quarterly Reports on Form 10-Q, including this Form 10-Q. 3 ITEM 1. CONDENSED C

View Full Filing

View this 10-Q filing on SEC EDGAR